Pulmonary

PONV Risk Assessment

Apfel score · Postoperative nausea and vomiting · Antiemetic prophylaxis

Assess postoperative nausea and vomiting risk with the Apfel score to support selection of antiemetic prophylaxis.

Based on: Apfel 1999 · SAMBA 2020

Clinical decision support for perioperative care. · About this platform

Input

Apfel Score
0/ 4
Risk factors

Overview

Apfel simplified risk score for postoperative nausea and vomiting (PONV). Four independent predictors classify patients into low, moderate, or high risk and guide the number of prophylactic antiemetic agents and anesthetic technique.

Evidence Summary

The Apfel simplified risk score was derived and validated by Apfel et al. (1999) in a large multicenter trial. Female sex is the strongest predictor, followed by history of PONV or motion sickness, non-smoking status, and planned postoperative opioids — each contributing equally (1 point). The score reliably stratifies patients into four incidence bands.

Apfel score — PONV incidence and prophylaxis recommendation
ScorePONV incidenceRiskRecommended approach
0≈10%LowNo routine prophylaxis
1≈21%LowConsider single agent
2≈39%ModerateTwo-drug combination
3≈61%HighMultimodal ≥2 classes + consider TIVA
4≈79%HighMultimodal ≥2 classes + TIVA

SAMBA 2020 guidelines recommend a multimodal approach for moderate-to-high risk patients, combining agents from different mechanism classes (5-HT3 antagonists, corticosteroids, NK1 antagonists, dopamine antagonists). For rescue therapy, guidelines consistently recommend using a drug from a different class than what was used for prophylaxis.

Learn More

Learn the pulmonary risk pathway

Review how ARISCAT, oxygenation, ABG, pneumonia severity, and postoperative respiratory risk fit together.

Open Pulmonary Education